Summit Therapeutics Inc (NASDAQ: SMMT) Could Be A Good Bet If You’re A Risk-Capital Investor
In the last trading session, 1.73 million shares of the Summit Therapeutics Inc (NASDAQ:SMMT) were traded, and its beta was -1.09. Most recently the company’s